A State-Of-The-Art Review of the Recent Advances in Drug Delivery Systems for Different Therapeutic Agents in Periodontitis Publisher Pubmed



Fayazi M¹ ; Rostami M² ; Amiri Moghaddam M³ ; Nasiri K⁴ ; Tadayonfard A⁵ ; Roudsari MB⁶ ; Ahmad HM⁷ ; Parhizgar Z⁸ ; Majbouri Yazdi A⁹ Show Affiliations
Source: Journal of Drug Targeting Published:2025

Abstract

Periodontitis (PD) is a chronic gum illness that may be hard to cure for a number of reasons, including the fact that no one knows what causes it, the side effects of anti-microbial treatment, and how various kinds of bacteria interact with one another. As a result, novel therapeutic approaches for PD treatment must be developed. Additionally, supplementary antibacterial regimens, including local and systemic medication administration of chemical agents, are necessary for deep pockets to assist with mechanical debridement of tooth surfaces. As our knowledge of periodontal disease and drug delivery systems (DDSs) grows, new targeted delivery systems like extracellular vesicles, lipid-based nanoparticles (NPs), metallic NPs, and polymer NPs have been developed. These systems aim to improve the targeting and precision of PD treatments while reducing the systemic side effects of antibiotics. Nanozymes, photodermal therapy, antibacterial metallic NPs, and traditional PD therapies have all been reviewed in this research. Medicinal herbs, antibiotics, photothermal therapy, nanozymes, antibacterial metallic NPs, and conventional therapies for PD have all been examined in this research. After that, we reviewed the key features of many innovative DDSs and how they worked for PD therapy. Finally, we have discussed the advantages and disadvantages of these DDSs. © 2024 Informa UK Limited, trading as Taylor & Francis Group.